Selectivity | Name | MT-2 | MT-4 | C8166 | C10/MJ | CEM | Jurkat | Reported activities of molecules (IC50 in nM) | |
---|---|---|---|---|---|---|---|---|---|
 |  |  | Infected | Uninfected |  | ||||
High | BMS-345541 | (10 uM) | ++++* | +++ | +++ | + | - ** | - | IKK-1(4), IKK-2(0.3) |
 | Purvalanol A | (10 uM) | ++++ | ++ | ++ | - | - | - | CDK1(4), CDK2(70), CDK5(75) |
 | Indirubin-3'-monoxime | (10 uM) | +++ | +++ | +++ | +++ | ++ | ++ | CDK1(180), CDK2(250), CDK4(3330), CDK5(100) |
 | Indirubin-3'-monoxime-5'-Iodo | (10 uM) | +++ | +++ | +++ | +++ | ++ | ++ | CDK1(25), CDK5(20) |
 | 9-Cyanopaullone | (10 uM) | ++++ | + | - | - | - | - | CDK1(24), CDK5(44) |
 | Aloisine A | (10 uM) | +++ | + | - | - | - | - | CDK1(150), CDK2(120), CDK5(200) |
 | Compound 52 | (10 uM) | +++ | + | - | - | - | - | CDK1(340) |
 | Flavopiridol | (0.1 uM) | ++ | + | - | - | - | - | CDK9(50) |
Moderate | r-Roscovitine | (10 uM) | ++ | - | - | - | - | - | CDK1(650), CDK2(700), CDK5(160), CDK7(500) |
 | Bohemine | (10 uM) | ++ | - | - | - | - | - | CDK1(1000) |
 | s-Roscovitine | (10 uM) | + | - | - | - | - | - | CDK1(650), CDK2(700), CDK5(160), CDK7(500) |
 | WHI-P180 | (10 uM) | + | N/A | N/A | - | N/A | N/A | CDK2(1000) |
 | Kenpaullone | (10 uM) | + | - | - | - | - | - | CDK1(400), CDK2(680), CDK5(850) |
 | 2,6-Diaminopurine | (10 uM) | - | + | - | - | - | - |  |
 | Flavone | (10 uM) | + | - | - | - | - | - | CDK1(300), CDK2(100), CDK4(400), CDK7(300) |
 | Alsterpaullone | (10 uM) | ++++ | ++ | +++ | + | ++ | ++ | CDK1(35), CDK2(15), CDK5(40) |
 | CGP 74514A | (10 uM) | ++++ | ++ | +++ | + | ++ | ++ | CDK1(25) |
 | BAY 11-7085 | (10 uM) | + | ++++ | +++ | N/A | ++++ | ++++ |  |
 | BAY 11-7082 | (10 uM) | + | ++++ | +++ | N/A | ++++ | ++++ | IkBa(10000) |
 | CAPE | (10 uM) | + | +++ | - | N/A | ++++ | ++++ |  |
 | Diethylmaleate | (10 uM) | + | +++ | - | N/A | ++++ | ++++ |  |
 | Parthenolide | (10 uM) | + | +++ | +++ | N/A | ++++ | ++++ |  |
 | Pyrrolidinedithiocarbamic acid | (10 uM) | - | +++ | +++ | N/A | ++++ | ++++ |  |
 | Wedelolactone | (10 uM) | + | ++ | - | N/A | ++ | ++ |  |
Poor | 6-Benzyloxypurine | (10 uM) | - | - | - | - | - | - | Â |
 | 5-amino alicylic acid | (10 uM) | - | - | - | N/A | - | - |  |
 | 2,6-Dichloropurine | (10 uM) | - | - | - | - | - | - |  |
 | 6-Dimethylaminopurine | (10 uM) | - | - | - | - | - | - | CDC |
 | Indirubin-3'-monoxime-5'-sulphonic acid | (10 uM) | - | - | - | - | - | - | CDK1(5), CDK5(7) |
 | Iso-olomoucine | (10 uM) | - | - | - | - | - | - | CDK1(>500,000), CDK4,5(>1,000,000) |
 | N-6-(Δ2-Isopentyl)-adenine | (10 uM) | - | - | - | - | - | - | CDK1,2,5(>50,000) |
 | Olomoucine | (10 uM) | - | - | - | - | - | - | CDK1,2(7000), CDK5(3000) |
 | Olomoucine, N9-isopropyl | (10 uM) | - | - | - | - | - | - | CDK1(2000) |
 | SC-514 | (10 uM) | - | - | - | - | - | - | IKK-1(>200), IKK-2(11.2) |
 | QNZ | (10 uM) | - | - | - | N/A | ++ | + |  |
 | * positive sign indicates level of cell inhibition |  | Inhibition | Percentage |  |  |  |  |  |
 | ** negative sign indicates no cell inhibition |  | - | 1–5% |  |  |  |  |  |
 |  |  | + | 25% |  |  |  |  |  |
 |  |  | ++ | 50% |  |  |  |  |  |
 |  |  | +++ | 75% |  |  |  |  |  |
 |  |  | ++++ | 90% |  |  |  |  |  |